MindWalk Holdings (NASDAQ: HYFT) shares closed down 18% at $1.18 after the company reported a quarterly loss of $0.06 per share, missing the $0.05 consensus by 20%.
A cluster of biopharma names moved sharply in the same session on a wide range of corporate, clinical, and financing news, spanning one standout earnings-driven rally, one severe dilution-driven collapse, a finalized cross-border merger, and five separate declines tied to financing actions, an earnings …
Niki BioSolutions, Inc. (NASDAQ: NIKI) shares closed down 5% at $8.58 after the company revealed that DiamiR Biosciences, its subsidiary, has contracted with Progressive Medical Research (PMR) to deliver Apolipoprotein E (APOE) genotyping services.
HCW Biologics (NASDAQ: HCWB) shares closed down 14% at $2.88 after the company requested a Type B pre-IND consultation with the FDA to coordinate on the clinical framework and regulatory roadmap for HCW11-018b.
Jaguar Health (NASDAQ: JAGX) shares closed down 23% at $1.03 after the company disclosed that its subsidiary, Napo Pharmaceuticals, has supplied a proprietary oral solution formulation of crofelemer for compassionate use.
FormFactor (NASDAQ:FORM) shares are attempting to stabilize in pre-market trading, rebounding modestly after tumbling roughly 8 percent in the prior session amid a broad semiconductor selloff. The stock's recent slide tracks a sector-wide rout triggered by SK Hynix's (NASDAQ:SKHY) underwhelming earnings reaction and mounting …
Fiverr International (NYSE:FVRR) shares are sliding sharply in pre-market trading after the company reported second-quarter revenue of $97.8 million, a 10.0 percent year-over-year decline, and cut its full-year 2026 guidance to reflect accelerated AI-related demand and traffic headwinds that have continued into the third …
CoStar Group (NASDAQ:CSGP) shares are plunging in pre-market trading despite the company beating second-quarter adjusted EPS estimates of $0.32 versus $0.29 expected, as investors focused on a revenue miss, with second-quarter revenue of $925 million falling short of a $928.8 million consensus, and disappointing …
Bloom Energy (NYSE:BE) shares are pulling back sharply in pre-market trading, giving back a large portion of Tuesday's after-hours pop that followed strong second-quarter results, as investors weigh strong fundamental performance against valuation concerns after a huge 2026 run. The company posted adjusted earnings …
FuelCell Energy (NASDAQ:FCEL) shares are rebounding modestly in pre-market trading after a sharp two-day pullback that saw the stock drop nearly 9 percent on Tuesday amid a broad selloff across the hydrogen and fuel cell complex, with peers Bloom Energy (NYSE:BE) and Plug Power …